scispace - formally typeset
F

Federica Zamporlini

Researcher at Marche Polytechnic University

Publications -  17
Citations -  632

Federica Zamporlini is an academic researcher from Marche Polytechnic University. The author has contributed to research in topics: NAD+ kinase & Nicotinamide phosphoribosyltransferase. The author has an hindex of 11, co-authored 14 publications receiving 403 citations.

Papers
More filters
Journal ArticleDOI

Bread enriched with cricket powder (Acheta domesticus): A technological, microbiological and nutritional evaluation

TL;DR: It is demonstrated that edible insects powder can successfully be included in leavened baked goods to enhance their protein content, proving that edible Insects can constitute a novel source of innovative ingredients to be used in bread making.
Journal ArticleDOI

Protein fortification with mealworm (Tenebrio molitor L.) powder: Effect on textural, microbiological, nutritional and sensory features of bread.

TL;DR: Results of sensory analyses revealed that protein fortification of bread with MP significantly affected bread texture and overall liking, as well as crust colour, depending on the substitution level, suggesting that the production of breads with MP might easily be scaled up at industrial level.
Journal ArticleDOI

NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo.

TL;DR: NMN deamidase reduces NMN accumulation in injured mouse sciatic nerves and preserves some axons for up to three weeks, even when expressed at a low level, and rescues axonal outgrowth and perinatal lethality in a dose-dependent manner in mice lacking NMNAT2.
Journal ArticleDOI

Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites

TL;DR: The identification of Vacor as a substrate metabolized by the consecutive action of NAMPT and NMNAT2 into the NAD analog Vacor adenine dinucleotide (VAD) causes unprecedented rapid NAD depletion, glycolytic block, energy failure, and necrotic death of NM NAT2-proficient cancer cells.